Copyright Reports & Markets. All rights reserved.

Global Non-Invasive Prenatal Testing (NIPT) Market Research Report 2012-2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Objectives of Research
      • 1.1.1 Definition
      • 1.1.2 Specifications
    • 1.2 Market Segment
      • 1.2.1 by Type
        • 1.2.1.1 Ultrasound Detection
        • 1.2.1.2 Biochemical Screening Tests
        • 1.2.1.3 Cell-Free Dna In Maternal Plasma Tests
        • 1.2.1.4 Fetal Cells In Maternal Blood Tests
        • 1.2.1.5 Others
      • 1.2.2 by Application
        • 1.2.2.1 Hospitals
        • 1.2.2.2 Clinics
        • 1.2.2.3 Research Laboratories
      • 1.2.3 by Regions

    2 Industry Chain

    • 2.1 Industry Chain Structure
    • 2.2 Upstream
    • 2.3 Market
      • 2.3.1 SWOT
      • 2.3.2 Dynamics

    3 Environmental Analysis

    • 3.1 Policy
    • 3.2 Economic
    • 3.3 Technology
    • 3.4 Market Entry

    4 Market Segmentation by Type

    • 4.1 Market Size
      • 4.1.1 Ultrasound Detection Market, 2013-2018
      • 4.1.2 Biochemical Screening Tests Market, 2013-2018
      • 4.1.3 Cell-Free Dna In Maternal Plasma Tests Market, 2013-2018
      • 4.1.4 Fetal Cells In Maternal Blood Tests Market, 2013-2018
      • 4.1.5 Others Market, 2013-2018
    • 4.2 Market Forecast
      • 4.2.1 Ultrasound Detection Market Forecast, 2019-2024
      • 4.2.2 Biochemical Screening Tests Market Forecast, 2019-2024
      • 4.2.3 Cell-Free Dna In Maternal Plasma Tests Market Forecast, 2019-2024
      • 4.2.4 Fetal Cells In Maternal Blood Tests Market Forecast, 2019-2024
      • 4.2.5 Others Market Forecast, 2019-2024

    5 Market Segmentation by Application

    • 5.1 Market Size
      • 5.1.1 Hospitals Market, 2013-2018
      • 5.1.2 Clinics Market, 2013-2018
      • 5.1.3 Research Laboratories Market, 2013-2018
    • 5.2 Market Forecast
      • 5.2.1 Hospitals Market Forecast, 2019-2024
      • 5.2.2 Clinics Market Forecast, 2019-2024
      • 5.2.3 Research Laboratories Market Forecast, 2019-2024

    6 Market Segmentation by Region

    • 6.1 Market Size
      • 6.1.1 Asia-Pacific
        • 6.1.1.1 Asia-Pacific Market, 2012-2018
        • 6.1.1.2 Asia-Pacific Market by Type
        • 6.1.1.3 Asia-Pacific Market by Application
      • 6.1.2 North America
        • 6.1.2.1 North America Market, 2012-2018
        • 6.1.2.2 North America Market by Type
        • 6.1.2.3 North America Market by Application
      • 6.1.3 Europe
        • 6.1.3.1 Europe Market, 2012-2018
        • 6.1.3.2 Europe Market by Type
        • 6.1.3.3 Europe Market by Application
      • 6.1.4 South America
        • 6.1.4.1 South America Market, 2012-2018
        • 6.1.4.2 South America Market by Type
        • 6.1.4.3 South America Market by Application
      • 6.1.5 Middle East & Africa
        • 6.1.5.1 Middle East & Africa Market, 2012-2018
        • 6.1.5.2 Middle East & Africa Market by Type
        • 6.1.5.3 Middle East & Africa Market by Application
    • 6.2 Market Forecast
      • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
      • 6.2.2 North America Market Forecast, 2019-2024
      • 6.2.3 Europe Market Forecast, 2019-2024
      • 6.2.4 South America Market Forecast, 2019-2024
      • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

    7 Market Competitive

    • 7.1 Global Market by Vendors
    • 7.2 Market Concentration
    • 7.3 Price & Factors
    • 7.4 Marketing Channel

    8 Major Vendors

    • 8.1 GE Healthcare
    • 8.2 Koninklijke Philips
    • 8.3 BGI Genomics
    • 8.4 Illumina
    • 8.5 Thermo Fisher Scientific
    • 8.6 F. Hoffmann-La Roche
    • 8.7 Pacific Biosciences Of California
    • 8.8 Perkinelmer
    • 8.9 Qiagen
    • 8.10 Agilent Technologies
    • 8.11 LifeCodexx
    • 8.12 Berry Genomics
    • 8.13 LifeLabs Genetics
    • 8.14 Quest Diagnostics
    • 8.15 Safembryo
    • 8.16 Laboratory Corporation of America Holdings
    • 8.17 Natera
    • 8.18 Sequenom
    • 8.19 Ariosa Diagnostics
    • 8.20 CombiMatrix

    9 Conclusion

    Summary
    The global Non-Invasive Prenatal Testing (NIPT) market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
    Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
    Ultrasound Detection
    Biochemical Screening Tests
    Cell-Free Dna In Maternal Plasma Tests
    Fetal Cells In Maternal Blood Tests
    Others
    Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
    GE Healthcare
    Koninklijke Philips
    BGI Genomics
    Illumina
    Thermo Fisher Scientific
    F. Hoffmann-La Roche
    Pacific Biosciences Of California
    Perkinelmer
    Qiagen
    Agilent Technologies
    LifeCodexx
    Berry Genomics
    LifeLabs Genetics
    Quest Diagnostics
    Safembryo
    Laboratory Corporation of America Holdings
    Natera
    Sequenom
    Ariosa Diagnostics
    CombiMatrix
    Based on Application, the report describes major application share of regional market. Application mentioned as follows:
    Hospitals
    Clinics
    Research Laboratories
    Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa

    Buy now